ArticleBMC medical imaging2026
A multicenter-validated interpretable transformer model for pituitary microadenoma detection on non-contrast multiparametric MRI.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDetecting pituitary microadenomas using non-contrast multi-parametric magnetic resonance imaging (MRI) is challenging yet essential for clinical decisions. This study aimed to develop a transformer deep learning (DL) model for detecting pituitary microadenomas based on non-contrast multiparametric MRI and explore the explainability techniques to enhance transparency in convolutional neural network (CNN)-based classification. The primary research question addressed is how to improve the accuracy, generalization, and interpretability of CNNs for microadenomas detection.
methodsNon-contrast multiparametric MRI sella area scans of 590 patients were retrospectively collected from three hospitals. The development and comparison of 2D_DL, 2.5D_DL, 2D_multichannel, and transformer models for classification. By incorporating Explainable AI (XAI), including Gradient-weighted Class Activation Mapping(Grad-CAM) and SHapley Additive exPlanations (SHAP), we improve model interpretability.
resultsThe performance of the 2D_multichannel model, with an area under the curve (AUC) of 0.893, was better to that of the 2D_T1SAG_DL, 2D_T1COR_DL, 2D_T2COR_DL (AUC, 0.884, 0.779, and 0.846, respectively). The performance of the transformer model, with an area under the curve (AUC) of 0.985, was superior to that of the 2.5D_T1SAG_DL, 2.5D_T1COR_DL, 2.5D_T2COR_DL (AUC, 0.763, 0.863, and 0.835, respectively). The non-contrast MRI-based 2.5D_DL transformer model all shows outperforming performance in the internal and two external test sets (AUC, 0.874, 0.829, and 0.819, respectively).
conclusionsGiven its robust diagnostic performance and enhanced interpretability, this model demonstrates significant potential for clinical translation as a decision-support tool in the detection of pituitary microadenomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.